Search the TFS Resource Library

Search by keyword, or choose a Therapeutic Area to view all resources within that area of study.

  • All
  • Articles
  • Case Studies
  • Infographics
  • Reference Sheets
  • Webinars
  • White Papers
  • Other
  • Clear Filters
Found 74 Results
Page 1 of 13
Webinars

The new endpoints reshaping oncology trial design

The endpoint and eligibility shifts reshaping oncology trial design in 2026. Watch the full replay or download the slides.

Watch Now
Case Study

Getting real-world evidence to the sponsor before the deadline, not after

When a tight oncology RWE deadline moved forward by 10 days, TFS HealthScience restructured the team and delivered. Download the case study to find out how.

Download
Case Study

AI is changing how we answer the first question on every trial: can this be done, where and how fast?

TFS HealthScience is implementing AI to deliver feasibility assessments faster. See how AI and human judgement work together to answer every trial’s first question.

Download
Case Study

How our Medical Writing Team went from Synopsis to Protocol in two months

How the TFS Medical Writing team delivered a clinic-ready protocol in two months, from a single slide deck.

Download
White paper

FSP vs Full-service CRO: a plain-English guide for German and Swiss Biotech

A plain-English breakdown of FSP vs full-service CRO for DACH biotech, covering local regulatory context and what to look for in a partner.

Download
White paper

Navigating the Regulatory and Scientific Complexities of Combination Therapy Protocols

Combination therapy trials require clear, compliant protocols to manage complexity and risk. Download our white paper for expert medical writing insights on effective protocol development.

Download

Latest Articles

Found 199 Results
Page 1 of 23
Article

Up to 1 in 3 sarcoma diagnoses change on second review

TFS HealthScience on what sponsors should ask before a sarcoma programme begins and how we build protocols around real clinical practice.

Read Now
Article

Designed with, not for: co-designing clinical trials with patients at the table, not in the waiting room

Most CROs bring patient groups in after the protocol is locked. TFS HealthScience explains why that timing determines whether co-design actually works.

Read Now
Article

Juneteenth and the next chapter of medicine

From site selection to protocol design, inclusive trials produce better science. TFS HealthScience on closing the representation gap.

Read Now
Article

This Pride Month see the life behind every number

LGBTQ+ patients want to take part in clinical research. Most are never asked. Here is what the science says and what better recruitment looks like in practice.

Read Now
Article

10 oncology trial readouts to watch for at ASCO 2026

Biomarker-defined populations. Rare cancers. Multi-country designs. As ASCO 2026 approaches, TFS HealthScience outlines the ten oncology trials that matter most and what they mean for sponsors planning their next programme.

Read Now
Article

From single-injection vision restoration to gene therapy: what precision ophthalmology means for trial design in 2026

Learn how ARVO 2026 signals a new era of precision ophthalmology, where smarter recruitment, imaging consistency and patient‑centric design demand deep‑tier partnerships like those offered by TFS.

Read Now
Article
News

Is your ClinicalTrials.gov results submission overdue?

The FDA reminded over 2,200 sponsors to submit overdue ClinicalTrials.gov results. This how TFS Medical Writing team can help.

Read Now
Article

The Value of Cross-Functional Expertise in Complex Oncology Clinical Trials

Experienced Oncology CROs with cross-functional expertise strengthen complex oncology clinical trials and accelerates clinical development.

Read Now
Article

Top 5 Challenges in Psoriasis Clinical Trials (and How to Overcome Them)

Psoriasis clinical trials face predictable hurdles, from patient recruitment shortfalls to regulatory complexity. This blog explores the five most common challenges and practical strategies sponsors can use to overcome them.

Read Now